High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes

被引:70
作者
Shi, MM [1 ]
Myrand, SP
Bleavins, MR
de la Iglesia, FA
机构
[1] Warner Lambert Co, Parke Davis Pharmaceut Res, Genom Pathol Lab, Pathol & Expt Toxicol, Ann Arbor, MI 48105 USA
[2] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
来源
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY | 1999年 / 52卷 / 05期
关键词
NAD(P)H quinone oxidoreductase; genotyping; TaqMan;
D O I
10.1136/mp.52.5.295
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-The two electron reduction of quinones to hydroquinones by NAD(P)H quinone oxidoreductase (NQO1) plays an important role in both activation and detoxification of quinone and similarly reactive compounds. A single nucleotide polymorphism at exon 6 leads to an amino acid change at codon 187 from proline to serine. The variant allele has been associated with decreased NQO1 enzyme activity and increased cancer risks. The aim of this study was to develop a rapid genotyping procedure for epidemiological and clinical research into the potential biological and toxicological implications associated with this genetic polymorphism. Methods-A high throughput genotyping method using fluorogenic probes has been developed to screen this single nucleotide polymorphism. This assay utilises the 5' nuclease activity of Tag polymerase in conjunction with fluorogenic TaqMan probes. The TaqMan genotyping procedure was validated by a restriction fragment length polymorphism method and direct sequencing. Results-This method can be used for the rapid screening of known polymorphisms in large populations. In a population of 143 unrelated individuals, Pro/Pro (wildtype), Pro/Ser (heterozygous), and Ser/Ser (mutant) genotypes were 69.2%, 26.6%, and 4.2%, respectively. Conclusions-This genotyping method is highly accurate and could be applied to automated large scale genotyping studies.
引用
收藏
页码:295 / 299
页数:5
相关论文
共 16 条
[1]   ANTIOXIDANT AND PROOXIDANT FUNCTIONS OF DT-DIAPHORASE IN QUINONE METABOLISM [J].
CADENAS, E .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (02) :127-140
[2]   THE TOXICITY OF AROMATIC NITROCOMPOUNDS TO BOVINE LEUKEMIA VIRUS-TRANSFORMED FIBROBLASTS - THE ROLE OF SINGLE-ELECTRON REDUCTION [J].
CENAS, N ;
NEMEIKAITE, A ;
DICKANCAITE, E ;
ANUSEVICIUS, Z ;
NIVINSKAS, H ;
BIRONAITE, D .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1995, 1268 (02) :159-164
[3]   NAD(P)H:quinone oxidoreductase:: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations [J].
Gaedigk, A ;
Tyndale, RF ;
Jurima-Romet, M ;
Sellers, EM ;
Grant, DM ;
Leeder, JM .
PHARMACOGENETICS, 1998, 8 (04) :305-313
[4]   Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy [J].
Kelsey, KT ;
Ross, D ;
Traver, RD ;
Christiani, DC ;
Zuo, ZF ;
Spitz, MR ;
Wang, M ;
Xu, X ;
Lee, BK ;
Schwartz, BS ;
Wiencke, JK .
BRITISH JOURNAL OF CANCER, 1997, 76 (07) :852-854
[5]   PRESENCE OF A HETEROZYGOUS SUBSTITUTION AND ITS RELATIONSHIP TO DT-DIAPHORASE ACTIVITY [J].
KUEHL, BL ;
PATERSON, JWE ;
PEACOCK, JW ;
PATERSON, MC ;
RAUTH, AM .
BRITISH JOURNAL OF CANCER, 1995, 72 (03) :555-561
[6]  
LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, P303
[7]  
LIVAK KJ, 1995, PCR METH APPL, V4, P357
[8]   STRUCTURE-SPECIFIC ENDONUCLEOLYTIC CLEAVAGE OF NUCLEIC-ACIDS BY EUBACTERIAL DNA-POLYMERASES [J].
LYAMICHEV, V ;
BROW, MAD ;
DAHLBERG, JE .
SCIENCE, 1993, 260 (5109) :778-783
[9]   DT-DIAPHORASE AND CANCER-CHEMOTHERAPY [J].
RILEY, RJ ;
WORKMAN, P .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (08) :1657-1669
[10]   A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): Relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity [J].
Ross, D ;
Traver, RD ;
Siegel, D ;
Kuehl, BL ;
Misra, V ;
Rauth, AM .
BRITISH JOURNAL OF CANCER, 1996, 74 (06) :995-996